1. Tanshinone IIA inhibits cervix carcinoma stem cells migration and invasion via inhibiting YAP transcriptional activity
    Jinghao Qin et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  2. Tanshinone IIA increases protein expression levels of PERK, ATF6, IRE1α, CHOP, caspase-3 and caspase-12 in pancreatic cancer BxPC-3 cell-derived xenograft tumors
    Tsung-Lang Chiu et al, 2017, Molecular Medicine Reports CrossRef
  3. Tanshinone IIA promotes the proliferation of WB-F344 hepatic oval cells via Wnt/β-catenin signaling
    XINGYU ZE et al, 2016, Molecular Medicine Reports CrossRef
  4. Anti-cancer effect of danshen and dihydroisotanshinone I on prostate cancer: targeting the crosstalk between macrophages and cancer cells via inhibition of the STAT3/CCL2 signaling pathway
    Ching-Yuan Wu et al, 2017, Oncotarget CrossRef
  5. Role of glioblastoma stem cells in cancer therapeutic resistance: a perspective on antineoplastic agents from natural sources and chemical derivatives
    Ana Laura V. Alves et al, 2021, Stem Cell Research & Therapy CrossRef
  6. Tanshinone IIA acts as a regulator of lipogenesis to overcome osimertinib acquired resistance in lung cancer
    Lin Cao et al, 2024, Biochemical Pharmacology CrossRef
  7. Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science
    Yuening Xiang et al, 2019, Cancer Medicine CrossRef
  8. Tanshinone IIA: A Review of its Anticancer Effects
    Zhong‐ying Fang et al, 2021, Frontiers in Pharmacology CrossRef
  9. Fsk and IBMX inhibit proliferation and proapoptotic of glioma stem cells via activation of cAMP signaling pathway
    Peng Lv et al, 2019, Journal of Cellular Biochemistry CrossRef
  10. Combination therapy of tanshinone IIA and puerarin for pulmonary fibrosis via targeting IL6‐JAK2‐STAT3/STAT1 signaling pathways
    Zhifeng Xue et al, 2021, Phytotherapy Research CrossRef
  11. Tanshinone IIA targeting cell signaling pathways: a plausible paradigm for cancer therapy
    Syed Sahajada Mahafujul Alam et al, 2023, Pharmacological Reports CrossRef
  12. Tanshinone IIA enhances chemosensitivity of colon cancer cells by suppressing nuclear factor-κB
    YANGQIU BAI et al, 2016, Experimental and Therapeutic Medicine CrossRef
  13. Tanshinone IIA Suppresses Glioma Cell Proliferation, Migration and Invasion Both in vitro and in vivo Partially Through miR-16-5p/Talin-1 (TLN1) Axis


    Shihao You et al, 2020, Cancer Management and Research CrossRef
  14. Network pharmacological analysis of active components of Xiaoliu decoction in the treatment of glioblastoma multiforme
    Ji Wu et al, 2022, Frontiers in Genetics CrossRef
  15. WITHDRAWN: Tanshinone IIA-mediated inhibition on miR-125b/STARD13 axis attenuates the stemness and enhances adriamycin sensitivity of breast cancer cells
    Xiaoman Li et al, 2019, Biochimie CrossRef
  16. Effects of Tanshinone IIA on osteogenic differentiation of mouse bone marrow mesenchymal stem cells
    Kejun Qian et al, 2015, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
  17. Cryptotanshinone attenuates the stemness of non-small cell lung cancer cells via promoting TAZ translocation from nuclear to cytoplasm
    Linling Jin et al, 2020, Chinese Medicine CrossRef
  18. Tanshinone IIA attenuates the stemness of breast cancer cells via targeting the miR-125b/STARD13 axis
    Xiaoman Li et al, 2022, Experimental Hematology & Oncology CrossRef
  19. Tanshinones and mental diseases: from chemistry to medicine
    Sana Javed et al, 2016, Reviews in the Neurosciences CrossRef
  20. Silencing stem cell factor attenuates stemness and inhibits migration of cancer stem cells derived from Lewis lung carcinoma cells
    Li Wang et al, 2016, Tumor Biology CrossRef
  21. A comprehensive review on the use of traditional Chinese medicine for cancer treatment
    Neha Yadav et al, 2024, Pharmacological Research - Modern Chinese Medicine CrossRef
  22. A review of natural products and small‐molecule therapeutics acting on central nervous system malignancies: Approaches for drug development, targeting pathways, clinical trials, and challenges
    Ardalan Pasdaran et al, 2024, Drug Development Research CrossRef
  23. The Synergistic Antitumor Effect of Tanshinone IIA Plus Adriamycin on Human Hepatocellular Carcinoma Xenograft in BALB/C Nude Mice and Their Influences on Cytochrome P450 CYP3A4 In Vivo
    Tao-Li Liu et al, 2020, Advances in Medicine CrossRef
  24. Cancer stem cells in brain tumors: From origin to clinical implications
    Shuyun Lin et al, 2023, MedComm CrossRef
  25. Resveratrol sensitizes glioblastoma-initiating cells to temozolomide by inducing cell apoptosis and promoting differentiation
    HAO LI et al, 2016, Oncology Reports CrossRef
  26. Terpenes: A hope for glioblastoma patients
    Eva María Domínguez-Martín et al, 2023, New Insights Into Glioblastoma CrossRef
  27. Tanshinone IIA: New Perspective on the Anti-Tumor Mechanism of A Traditional Natural Medicine
    Wenfeng Zhang et al, 2022, The American Journal of Chinese Medicine CrossRef
  28. Preparation and characterisation of solid dispersions of tanshinone IIA, cryptotanshinone and total tanshinones
    Xifeng Zhai et al, 2017, Asian Journal of Pharmaceutical Sciences CrossRef
  29. Enhanced Sestrin expression through Tanshinone 2A treatment improves PI3K-dependent inhibition of glioma growth
    Judith Schaf et al, 2023, Cell Death Discovery CrossRef
  30. Anticancer Activity of Salvia miltiorrhiza and Its Secondary Metabolites
    Ching-Fen Wu et al, 2017, Salvia Biotechnology CrossRef